Vaccinex, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Vaccinex, Inc. (VCNX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$339.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-14
- Vaccinex, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$3.66M.
- Vaccinex, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $3.32M.
- Vaccinex, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$5.64M, a 250.36% decline year-over-year.
- Vaccinex, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $9.96M.
- Vaccinex, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $1.44M, a 42.91% decline from fiscal 2017.
- Vaccinex, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.52M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-06-30 | -$3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$339.00K 10-Q · filed 2019-08-14 | -$5.98M derived: sum of 3 quarters · filed 2019-08-14 | $3.98M derived: sum of 4 quarters · filed 2019-08-14 |
| 2019-03-31 | $3.32M 10-Q · filed 2019-05-15 | -$2.32M derived: sum of 2 quarters · filed 2019-05-15 | $7.64M derived: sum of 3 quarters · filed 2019-05-15 | $6.02M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-12-31 | -$5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $4.32M derived: sum of 2 quarters · filed 2019-03-13 | $2.69M derived: sum of 3 quarters · filed 2019-08-14 | $1.44M 10-K · filed 2019-03-13 |
| 2018-09-30 | $9.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $8.33M derived: sum of 2 quarters · filed 2019-08-14 | $7.08M 10-Q · filed 2018-11-13 | $10.83M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$2.88M 10-Q · filed 2019-08-14 | $869.00K derived: sum of 3 quarters · filed 2019-08-14 | $132.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$1.26M 10-Q · filed 2019-05-15 | $2.50M derived: sum of 2 quarters · filed 2019-05-15 | $1.76M derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $3.01M derived: sum of 2 quarters · filed 2019-03-13 | $2.52M 10-K · filed 2019-03-13 | |
| 2017-09-30 | -$737.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$1.23M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$495.00K 10-Q · filed 2018-08-14 |